THE MCMANUS GROUP for DENDREON PHARMACEUTICALS LLC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 19, 2020 | $30,000 | Replaced |
| 1st Quarter - Amendment | Aug 6, 2020 | $30,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 and S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRYAN CRONAN | — |
| JOHN MCMANUS | LA, Bill Thomas. Staff Director, W&M Health Subcommittee |
| ALANNA TEMME | LD, Rep. Jon Porter |
| BARRETT THORNHILL | LA, Sen. Crapo and Rep. Toomey. LA and Press Secretary, Rep. Norwood. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.